1. 179 Immunotherapy trials lack a biomarker for inclusion: implications for drug development. (9th November 2020) Authors: Adashek, Jacob; Goloubev, Alexey; Kato, Shumei; Kurzrock, Razelle Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 179 Immunotherapy trials lack a biomarker for inclusion: implications for drug development. (9th November 2020) Authors: Adashek, Jacob; Goloubev, Alexey; Kato, Shumei; Kurzrock, Razelle Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort. (9th November 2020) Authors: Chae, Young Kwang; Othus, Megan; Patel, Sandip; Fenton, Sarah; Wang, Ding; Rodriguez, Cristina; Onitilo, Adedayo; Mattour, Ahmad; Rybkin, Igor; Hayward, Jourdain; McLeod, Christine; Chen, Helen; Sharon, Elad; Mayerson, Edward; Ryan, Christopher; Plets, Melissa; Blanke, Charles; Kurzrock, Razelle Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 270 A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the thyroid tumor cohort. (9th November 2020) Authors: Chae, Young Kwang; Othus, Megan; Patel, Sandip; Fenton, Sarah; Wang, Ding; Rodriguez, Cristina; Onitilo, Adedayo; Mattour, Ahmad; Rybkin, Igor; Hayward, Jourdain; McLeod, Christine; Chen, Helen; Sharon, Elad; Mayerson, Edward; Ryan, Christopher; Plets, Melissa; Blanke, Charles; Kurzrock, Razelle Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). (9th November 2020) Authors: Wagner, Michael; Othus, Megan; Patel, Sandip; Ryan, Christopher; Sangal, Ashish; Powers, Benjamin; Budd, George; Victor, Adrienne; Hsueh, Chung-Tsen; Chugh, Rashmi; Nair, Suresh; Leu, Kirsten; Agulnik, Mark; Sharon, Elad; Mayerson, Edward; Plets, Melissa; Blanke, Charles; Streicher, Howard; Chae,... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). (9th November 2020) Authors: Wagner, Michael; Othus, Megan; Patel, Sandip; Ryan, Christopher; Sangal, Ashish; Powers, Benjamin; Budd, George; Victor, Adrienne; Hsueh, Chung-Tsen; Chugh, Rashmi; Nair, Suresh; Leu, Kirsten; Agulnik, Mark; Sharon, Elad; Mayerson, Edward; Plets, Melissa; Blanke, Charles; Streicher, Howard; Chae,... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma. (September 2017) Authors: Vergote, Ignace B.; Smith, David C.; Berger, Raanan; Kurzrock, Razelle; Vogelzang, Nicholas J.; Sella, Avishay; Wheler, Jennifer; Lee, Yihua; Foster, Paul G.; Weitzman, Ron; Buckanovich, Ronald J. Journal: European journal of cancer Issue: Volume 83(2017) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase II basket trial of Dual Anti–CTLA–4 and Anti–PD–1 Blockade in Rare Tumors (DART) SWOG S1609: High‐grade neuroendocrine neoplasm cohort. Issue 17 (21st April 2021) Authors: Patel, Sandip Pravin; Mayerson, Edward; Chae, Young Kwang; Strosberg, Jonathan; Wang, Jue; Konda, Bhavana; Hayward, Jourdain; McLeod, Christine M.; Chen, Helen X.; Sharon, Elad; Othus, Megan; Ryan, Christopher W.; Plets, Melissa; Blanke, Charles D.; Kurzrock, Razelle Journal: Cancer Issue: Volume 127:Issue 17(2021) Page Start: 3194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A pilot study of temsirolimus and body composition. Issue 4 (27th July 2013) Authors: Veasey-Rodrigues, Heloisa; Parsons, Henrique A.; Janku, Filip; Naing, Aung; Wheler, Jennifer J.; Tsimberidou, Apostolia M.; Kurzrock, Razelle Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 4:Issue 4(2013) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A Tale of Two Histiocytic Disorders. (8th January 2013) Authors: Janku, Filip; Munoz, Javier; Subbiah, Vivek; Kurzrock, Razelle Journal: Oncologist Issue: Volume 18:Number 1(2013) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗